ELISAFE: Baseline characteristics from an observational study to evaluate real-world safety of eliglustat in patients with Gaucher disease

被引：0

作者：

Batsu, Isabela ^{[1
]}

Accomando, Beverly ^{[1
]}

Gaemers, Sebastiaan J. M. ^{[2
]}

Sekulic, Davorka ^{[1
]}

机构：

[1] Sanofi, Cambridge, MA USA

[2] Sanofi, Amsterdam, Netherlands

来源：

MOLECULAR GENETICS AND METABOLISM | 2022年 / 135卷 / 02期

关键词：

D O I：

10.1016/j.ymgme.2021.11.036

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S21 / S22

页数：2

共 50 条

[31] Safety and effectiveness of taliglucerase alfa in patients with Gaucher disease: an interim analysis of real-world data from a multinational drug registry (TALIAS)
Lina Titievsky
Tilman Schuster
Ronnie Wang
Muhammad Younus
Andrew Palladino
Kabir Quazi
Michael P. Wajnrajch
Betina Hernandez
Pamela S. Becker
Neal J. Weinreb
Christina Chambers
Roy Mansfield
Louise Taylor
Li-Jung Tseng
Paige Kaplan
Orphanet Journal of Rare Diseases, 17
[32] Real-World Experiences with Taliglucerase Alfa Home Infusions for Patients with Gaucher Disease: A Global Cohort Study
Revel-Vilk, Shoshana
Mansfield, Royston
Feder-Krengel, Neta
Machtiger-Azoulay, Noya
Kuter, David
Szer, Jeff
Rosenbaum, Hanna
Ferreira, David Cavalcanti
Ruhrman-Shahar, Noa
Wajnrajch, Michael
Zimran, Ari
JOURNAL OF CLINICAL MEDICINE, 2023, 12 (18)
[33] Real-world experiences with taliglucerase alfa home infusions for patients with Gaucher disease: A global cohort study
Zimran, Ari
Mansfield, Roy
Feder-Krengel, Neta
Machtiger-Azoulay, Noya
Szer, Jeff
Rosenbaum, Hanna
Shahar, Noa Ruhrman
Wajnrajch, Michael
Revel-Vilk, Shoshana
MOLECULAR GENETICS AND METABOLISM, 2024, 141 (02)
[34] Baseline characteristics of the 30,000 patients enrolled in LUMINOUS™, a real-world study with ranibizumab
Brand, Christopher
Parikh, Soumil
Macfadden, Wayne
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
[35] Correction to: Efficacy and safety of belimumab in patients with lupus nephritis: a real-world retrospective observational study
Lin, Sishi
Zhang, Ji
You, Xiaohan
Chen, Bo
Liang, Yan
Zhou, Yin
Ding, Xiaokai
Lv, Yinqiu
Zhang, Huidi
Su, Bofeng
Bai, Yongheng
Chen, Chaosheng
RHEUMATOLOGY, 2024,
[36] Real-World Safety and Effectiveness of Denosumab in Patients with Osteoporosis: A Prospective, Observational Study in South Korea
Rhee, Yumie
Chang, Dong-Gune
Ha, Jeonghoon
Kim, Sooa
Lee, Yusun
Jo, Euna
Koh, Jung-Min
ENDOCRINOLOGY AND METABOLISM, 2022, 37 (03) : 497 - 505
[37] Real-world baseline data in patients established on migalastat for Fabry disease
Orsborne, Chris
Thompson, Lorraine
Jovanovic, Ana
MOLECULAR GENETICS AND METABOLISM, 2019, 126 (02) : S113 - S113
[38] Use of inhaler devices in elderly patients with respiratory disease: real-world observational study
Lee, Ha Youn
Lee, Byoung Jun
Jung, Keun Bum
Lim, Hyojung
EUROPEAN RESPIRATORY JOURNAL, 2019, 54
[39] Indian Real-world Evidence of Rivaroxaban Use in Coronary Artery Disease - A Prospective Observational Cohort Study (IN-RECORD): Study Design and Baseline Characteristics
Jayagopal, P. B.
Raghuraman, Bagirath
Khetan, Anup
Magarkar, Vilas
Premchand, Rajendra Kumar
Ezhilan, J.
Sharma, Vinod
Kumar, A. Sreenivas
Dabhade, Dhammdeep
Shewale, Rishikesh
Suryawanshi, Sachin
Vikneswaran, G.
JOURNAL OF THE PRACTICE OF CARDIOVASCULAR SCIENCES, 2023, 9 (03) : 172 - 177
[40] Baseline characteristics of patients treated with vedolizumab in Taiwan: real-world evidence from TSIBD registry
Lin, Wei-Chen
Chang, Chung-Hsin
Tu, Chia-Hung
Feng, I-Che
Chou, Jen-Wei
Chung, Chen-Shuan
Shieh, Ming-Jium
Yen, Hsu-Heng
Liu, Yuh-Hwa
Tai, Wei-Chen
Wu, Deng-Chyang
Hsu, Wen-Hung
Lu, Chien-Yu
Lu, Lung-Sheng
Tsai, Tzung-Jiun
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 304 - 305

← 1 2 3 4 5 →